טוען...
Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion
BACKGROUND: Two treatments, ranibizumab and dexamethasone implant, for visual impairment due to macular oedema (ME) secondary to retinal vein occlusion (RVO) have recently been studied in clinical trials. There have been no head to head comparisons of the two treatments, and improvement measured as...
שמור ב:
| הוצא לאור ב: | BMC Med Res Methodol |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4289570/ https://ncbi.nlm.nih.gov/pubmed/25533265 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2288-14-140 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|